Multiple sclerosis (MS) is an immunological disease that causes acute inflammatory lesions
and chronic inflammation in the CNS, leading to tissue damage and disability. As awareness …

Recent findings have provided a molecular basis for the combined contributions of
multifaceted risk factors for the onset of multiple sclerosis (MS). MS appears to start as a …

Multiple sclerosis (MS) is the most frequently seen demyelinating disease, with a prevalence
that varies considerably, from high levels in North America and Europe (> 100/100,000 …

Multiple sclerosis (MS) is a chronic and potentially highly disabling disorder with
considerable social impact and economic consequences. It is the major cause of non …

Objectives To study the safety and efficacy of vitamin D3 as an add on therapy to interferon β-
1b (IFNB) in patients with multiple sclerosis (MS). Methods 1 year, double blind, placebo …

The epidemiology of multiple sclerosis (MS) has been intensively studied. It is
conceptualised as a complex disease in which genetic and environmental factors act …

Past sun exposure and vitamin D supplementation have been associated with a reduction in
the risk of MS. We measured the serum concentration of 25-hydroxyvitamin D (25 [OH] D) at …

Background: Past sun exposure and vitamin D3 supplementation have been associated with
a reduced risk of multiple sclerosis (MS). There are no previous longitudinal studies of …

Background: The prevalence of multiple sclerosis (MS) in Istanbul, Turkey, is unknown. We
investigated the prevalence of MS in the district of Maltepe, Istanbul, Turkey. Methods: This …

Introduction: Worldwide, incidence and prevalence of multiple sclerosis (MS) have
increased over the last decades. We present a systematic epidemiological study with recent …